Medicare Enrolled

Dr. Michael Givertz, MD

Cardiovascular Disease · Brookline, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
111 CYPRESS ST, Brookline, MA 02445
8573070896
In practice since 2006 (20 years)
NPI: 1265499560 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Givertz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Givertz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Givertz

Dr. Michael Givertz is a cardiovascular disease specialist in Brookline, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Givertz performed 525 Medicare services across 394 unique beneficiaries.

Between the years covered by Open Payments, Dr. Givertz received a total of $147,630 from 20 pharmaceutical and/or device companies across 232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Givertz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 525 Medicare services $147,630 industry payments

Medicare Practice Summary

Medicare Utilization ↗
525
Medicare services
Bottom 22% in MA for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
394
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~26 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
161 $113 $599
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
87 $64 $292
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
70 $91 $416
EKG interpretation and report
A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report.
45 $6 $34
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
37 $67 $297
Heart muscle biopsy
A procedure to remove a small sample of heart muscle tissue for laboratory examination.
32 $161 $920
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
32 $79 $404
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
30 $147 $805
Evaluation of lower heart chamber assist device
Assessment of the function and status of a device that assists the lower chambers of the heart.
20 $33 $198
New patient office visit, complex (60-74 min) 11 $153 $801
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$147,630
Total received (2018-2024)
Avg $21,090/year across 7 years
Top 5% in MA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
232
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$139,165 (94.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,466 (5.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,940
2023
$16,548
2022
$25,399
2021
$16,162
2020
$15,688
2019
$47,754
2018
$20,141

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$5,250
Abbott Laboratories
$496
Medtronic, Inc.
$143
Merck Sharp & Dohme LLC
$50
Top 3 companies account for 99.2% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$46,333
Edwards Lifesciences Corporation
$36,500
Merck Sharp & Dohme LLC
$20,296
AstraZeneca Pharmaceuticals LP
$15,864
Acorda Therapeutics, Inc
$10,005
Eli Lilly and Company
$6,014
BAXTER HEALTHCARE
$4,203
Abbott Laboratories
$3,312
Medtronic Vascular, Inc.
$2,100
Actelion Pharmaceuticals US, Inc.
$1,122
ABIOMED
$584
TransMedics, Inc.
$439
Boehringer Ingelheim Pharmaceuticals, Inc.
$171
Medtronic, Inc.
$143
BIOTRONIK INC.
$140
United Therapeutics Corporation
$103
PFIZER INC.
$86
Amgen Inc.
$78
CVRx, Inc.
$72
ShockWave Medical, Inc
$64
Top 3 companies account for 69.9% of all-time payments
Associated products mentioned in payments ›
Barostim Neo System · CARDIOMEMS · FARXIGA · HEARTMATE TOUCH · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HeartWare HVAD · Impella · JARDIANCE · LOKELMA · MICRA · MK-1242 · Mitra Clip system · Organ Care System · Renal - PD · Repatha · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VYNDAMAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for cardiovascular disease in MA.

Looking for a cardiovascular disease specialist in Brookline?
Compare cardiologists in the Brookline area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
598
Per 100K population
82.5
County median income
$126,497
Nearest hospital
BOURNEWOOD HOSPITAL
1.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Givertz is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 5% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Givertz experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Givertz performed 161 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Givertz receive payments from pharmaceutical companies?
Yes. Dr. Givertz received a total of $147,630 from 20 companies across 232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Givertz's costs compare to other cardiologists in Brookline?
Dr. Givertz's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Givertz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →